Fusion Antibodies Share Price Prediction (2025–2030): Expert Analysis & Predictions
Jun 16, 2025 | By Team SR
Follow us
Follow usFusion Antibodies (FAB), listed on the UK stock exchange, has emerged as a key player in the biotechnology space. As of the latest update, the share price stands at 6.65 GBX, with no current changes reported in trading activity. In this article, we dive deep into the Fusion Antibodies share price forecast, explore market sentiments, and offer predictions for 2025 to 2030 based on expert analysis and historical performance.
About Fusion Antibodies (FAB)
Fusion Antibodies is a Belfast-based contract research organization (CRO) specializing in antibody engineering services. The company supports therapeutic drug and diagnostic product development, helping biopharma clients bring innovative treatments to market. With multiple client drugs entering clinical trials, Fusion Antibodies plays a vital role in the global healthcare pipeline.
Fusion Antibodies Share Price Forecast (Today & Tomorrow – UK Market)
- Fusion Antibodies share price forecast today UK: 6.65 GBX
- Fusion Antibodies share price forecast tomorrow: Expected to remain between 6.50 – 6.80 GBX considering the current trading inactivity and market trends.
Expert Outlook on Fusion Antibodies Share Price Prediction (2025–2030)
The company’s stable yet modest price, coupled with its growing reputation in antibody development, makes it a speculative investment with long-term growth potential. Below are the Fusion Antibodies share price forecasts for each year from 2025 to 2030.
Fusion Antibodies Share Price Forecast 2025
In 2025, the Fusion Antibodies share price forecast indicates a gradual increase as the company continues to gain traction in clinical partnerships and visibility. The price may rise from 6.80 GBX to 8.00 GBX by the end of the year.
| Month | Forecast Price (GBX) |
| January | 6.80 |
| February | 6.90 |
| March | 7.00 |
| April | 7.10 |
| May | 7.20 |
| June | 7.10 |
| July | 7.00 |
| August | 7.20 |
| September | 7.40 |
| October | 7.60 |
| November | 7.80 |
| December | 8.00 |
Fusion Antibodies Share Price Forecast 2026
Fusion Antibodies share price forecast 2026 shows accelerated growth, potentially due to successful client trials and increasing investor confidence. The price may reach 10.00 GBX by year-end.
| Month | Forecast Price (GBX) |
| January | 8.10 |
| February | 8.20 |
| March | 8.40 |
| April | 8.30 |
| May | 8.50 |
| June | 8.70 |
| July | 8.90 |
| August | 9.10 |
| September | 9.30 |
| October | 9.50 |
| November | 9.70 |
| December | 10.00 |
Fusion Antibodies Share Price Forecast 2027
In 2027, the share price continues its steady upward trajectory, supported by a growing pipeline and successful collaborations. The forecast ends at 12.20 GBX.
| Month | Forecast Price (GBX) |
| January | 10.20 |
| February | 10.30 |
| March | 10.50 |
| April | 10.60 |
| May | 10.80 |
| June | 11.00 |
| July | 11.20 |
| August | 11.40 |
| September | 11.60 |
| October | 11.80 |
| November | 12.00 |
| December | 12.20 |
RECOMMENDED FOR YOU
Fusion Antibodies Share Price Forecast 2028
2028 may bring a mild but consistent rally, with increased biotech funding and demand for antibody research. The share price may climb from 12.30 to 14.50 GBX.
| Month | Forecast Price (GBX) |
| January | 12.30 |
| February | 12.40 |
| March | 12.60 |
| April | 12.80 |
| May | 13.00 |
| June | 13.20 |
| July | 13.40 |
| August | 13.60 |
| September | 13.80 |
| October | 14.00 |
| November | 14.20 |
| December | 14.50 |
Fusion Antibodies Share Price Forecast 2029
2029 shows signs of a strong bullish trend, potentially driven by licensing deals or new partnerships. The Fusion Antibodies share price forecast suggests prices may touch 17.20 GBX.
| Month | Forecast Price (GBX) |
| January | 14.80 |
| February | 15.00 |
| March | 15.20 |
| April | 15.40 |
| May | 15.60 |
| June | 15.80 |
| July | 16.00 |
| August | 16.20 |
| September | 16.50 |
| October | 16.70 |
| November | 17.00 |
| December | 17.20 |
Fusion Antibodies Share Price Forecast 2030
By 2030, Fusion Antibodies is projected to reach maturity in its niche, with the price forecasted to peak at 20.80 GBX, over 3x from today’s value.
| Month | Forecast Price (GBX) |
| January | 17.50 |
| February | 17.80 |
| March | 18.10 |
| April | 18.40 |
| May | 18.70 |
| June | 19.00 |
| July | 19.30 |
| August | 19.60 |
| September | 19.90 |
| October | 20.20 |
| November | 20.50 |
| December | 20.80 |
Conclusion - Fusion Antibodies Share
Fusion Antibodies is gradually positioning itself as a biotech innovator with a strong service model. While its share price forecast today UK reflects low trading activity, the long-term projections show a promising upward trend. Investors interested in the healthcare and biotech sector may find Fusion Antibodies share price prediction compelling for future returns.
FAQs - Fusion Antibodies Share
What is the current share price of Fusion Antibodies?
What is the Fusion Antibodies share price forecast 2025?
What is the long-term Fusion Antibodies share price prediction for 2030?
Is Fusion Antibodies a good long-term investment?
Where is Fusion Antibodies listed?
Reference:
For Fusion Antibodies share more detailed information, visit trusted sources Yahoo Finance https://finance.yahoo.com/quote/FAB.L/history/
Disclaimer:
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.
Explore more:
Recommended Stories for You
Team SR Jun 14, 2025
Team SR Jun 16, 2025
Team SR Oct 18, 2024
Team SR Jun 14, 2025
Team SR May 23, 2024
